The Global Preclinical Imaging Market is Anticipated to Witness High Growth Owing to Rising Demand for Non-Invasive Techniques
 |
| Preclinical Imaging Market |
The global Preclinical Imaging market consists of various imaging modalities used for in-vivo imaging in small animals for research purposes in biological and preclinical studies. Preclinical Imaging allows researchers to non-invasively visualize and quantify biological processes at the molecular, cellular and anatomical level over time, in order to understand disease progression and evaluate the effectiveness of novel drug candidates or devices. Key Preclinical Imaging modalities include optical imaging, nuclear imaging, MRI, ultrasound, CT, and photoacoustic imaging.
The need for Preclinical Imaging modalities has
increased significantly owing to the growing research activities in drug
discovery and development processes by pharmaceutical companies. Optical
imaging dominates the market due to low cost and high-throughput capabilities
for screening and studying molecular biological processes in living subjects.
The Global Preclinical
Imaging Market is estimated to be valued at US$ 4.25 BN in 2024 and is expected
to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global Preclinical Imaging market are Bruker
Corporation, Siemens A.G., General Electric (GE), TriFoil Imaging, PerkinElmer,
Inc., VisualSonics Inc. (Fujifilm), Inc., Mediso Ltd., Agilent Technologies,
MILabs B.V., MR Solutions, and Molecubes. Bruker Corporation holds a dominant
share owing to its comprehensive portfolio of Preclinical Imaging solutions.
The key opportunities in the Preclinical
Imaging Market Demand include the development of multimodal imaging
systems integrating two or more modalities to provide complementary anatomical
and functional information. Furthermore, growing R&D expenditures in
emerging markets such as Asia Pacific is fueling the demand for Preclinical
Imaging solutions and driving global expansion efforts of major players.
Key players are also focusing on new product innovation and launches to expand
their product portfolio and cater to the increasing need for high-resolution
small animal imaging. For instance, MR solutions launched its 7 tesla small
animal MRI system with advanced technology to offer high resolution structural
and functional information. The growing pharma industry in developing nations
of Asia-Pacific and Latin America will continue to drive global expansion of
key players looking to tap into new revenue streams in these regions.
Market drivers: The rising investment by governments and private organizations
in preclinical research and drug development is a major factor propelling
market growth. In addition, increasing global burden of chronic and lifestyle
diseases has accelerated pharmaceutical R&D activities, thus augmenting
demand for preclinical studies and associated imaging modalities.
Market Restrains: However, the high cost of Preclinical Imaging systems and
maintenance is a major restraint for small research laboratories and academia
in developing nations. Stringent regulatory frameworks and lengthy approval
processes for new Preclinical Imaging systems also hampers market growth.
Additionally, lack of specialist workforce to operate complex Preclinical
Imaging equipment poses operational challenges.
Comments
Post a Comment